Related Experiment Video
Updated: Jun 14, 2026
12:09
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
43.0K
COVID-19 vaccination challenges: A mini-review
Zeinab Mohseni Afshar1, Mohammad Barary2,3, Rezvan Hosseinzadeh4
1Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Human Vaccines & Immunotherapeutics
|May 5, 2022
Summary
This study examines COVID-19 vaccine strategies, focusing on optimizing the interval between two doses to address global vaccine undersupply and maximize public health impact.
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- The COVID-19 pandemic caused by SARS-CoV-2 has resulted in significant global mortality and public health strain.
- Rapid development of COVID-19 vaccines offers a potential end to the pandemic.
- Initial vaccination efforts prioritized high-risk groups, leading to resource challenges and undersupply.
Purpose of the Study:
- To discuss and analyze various recommendations and guidelines for the time interval between COVID-19 vaccine doses.
- To explore different scenarios for administering the two-dose vaccine regimen.
Main Methods:
- Review of existing public health policies and scientific recommendations regarding vaccine dosing intervals.
- Analysis of strategies for efficient management of limited vaccine supplies.
Main Results:
- Lack of universal consensus on the optimal interval between vaccine doses.
- Implementation of policies to manage vaccine distribution due to undersupply.
- Exploration of diverse dosing strategies to maximize vaccine efficacy and coverage.
Conclusions:
- Optimizing the interval between COVID-19 vaccine doses is crucial for efficient resource allocation.
- Flexible dosing strategies may be necessary to address vaccine undersupply and achieve pandemic control.
Related Concept Videos
01:51Vaccinations
Overview
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...